Nom du produit:(5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride
IUPAC Name:1-(5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride
| Unité d'emballage | Stock disponible | Prix($) | Quantité |
|---|---|---|---|
| CM407465-250mg | 3-4 Weeks | ƿǶȺ |
|
|
|||
| Product Overview |
(5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride is a novel compound that has been studied for its potential therapeutic applications. It is a member of the triazole family, which is a group of compounds that are known for their ability to bind to and inhibit certain enzymes. This compound has been studied for its ability to inhibit the enzyme cyclooxygenase-2 (COX-2), which is an important target for the treatment of inflammation, pain, and other diseases. This review will discuss the synthesis method, scientific research applications, mechanism of action, biochemical and physiological effects, advantages and limitations for lab experiments, and potential future directions for this compound. |
| Synthesis and Application |
The synthesis of (5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride involves the reaction of 5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine with hydrochloric acid, followed by the addition of a base such as sodium hydroxide or potassium hydroxide. The reaction is carried out at a temperature of 80-90°C for 10-15 minutes, and the product is then isolated and purified by column chromatography. The most common application of (5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride is in the study of its ability to inhibit the enzyme cyclooxygenase-2 ((5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride). (5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride is an enzyme involved in the biosynthesis of prostaglandins, which are hormones that play a role in inflammation and pain. The inhibition of (5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride has been studied for its potential therapeutic applications in the treatment of inflammation, pain, and other diseases. |
| Future Directions |
The potential future directions for (5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)methanamine dihydrochloride include further studies on its mechanism of action, potential therapeutic applications, and toxicity. Additionally, more research is needed to explore its potential anti-cancer, anti-inflammatory, and anti-oxidant properties. Furthermore, studies are needed to determine if this compound can be used as a drug delivery system for other drugs. Finally, further research is needed to explore the potential synergistic effects of combining this compound with other drugs or compounds. |
Recherche 
+86 21 5895 0110 
